RESUMOIntrodução:A hemoglobina S (HbS) é uma das alterações hematológicas hereditárias de maior frequência na espécie humana. No Brasil, a anemia falciforme (AF) tem importância epidemiológica significativa em virtude da prevalência e da morbimortalidade que apresenta e por isso tem sido apontada como uma questão de saúde pública.Objetivo:Determinar a prevalência de HbS entre indivíduos de origem asiática, afro e euro-brasileira de um banco de sangue de Curitiba.Material e método:O estudo foi realizado no período de janeiro de 2008 a dezembro de 2009, no qual foram incluídos 83.213 doadores atendidos no Instituto Paranaense de Hemoterapia e Hematologia.Resultados e discussão:A prevalência geral de HbS na população estudada foi de 0,9%, sendo 0% entre asiático-brasileiros, 2,7% entre afro-brasileiros e 0,7% entre euro-brasileiros. Houve associação positiva, significativa estatisticamente, para o traço falcêmico nos afrodescendentes, com odds ratio (OR) de 4,01 e intervalo de confiança (IC) 3,42-4,72, com 95% de confiança.Conclusão:O presente trabalho demonstrou maiores índices de traço falcêmico em afro-brasileiros, o que corrobora dados publicados em outras regiões e estados brasileiros.

ABSTRACTIntroduction:Hemoglobin S (HbS) is one of the most common inherited hematological disorders in humans. In Brazil, the sickle-cell disease (SCD) has significant epidemiological importance due to its prevalence and the morbidity-mortality and, therefore, it has been identified as a matter of public health.Objective:To determine the prevalence of HbS among Asian Brazilian, Afro Brazilian, and Euro Brazilian individuals of a blood bank in Curitiba.Material and method:The study was conducted from January 2008 to December 2009, and included 83,213 donors seen at the Instituto Paranaense de Hemoterapia e Hematologia.Results and discussion:The prevalence of HbS in the studied population was 0.9%, among them, 0% Asian Brazilians, 2.7% Afro Brazilians, and 0.7% Euro Brazilians. There was a positive association, statistically significant for the sickle cell trait in Afro-descendants, with odds ratio (OR) 4.01; confidence interval (CI) 3.42-4.72; and 95% confidence.Conclusion:This study showed higher rates of sickle cell trait in Afro Brazilians, which corroborates data published in other Brazilian regions and states.

This study aimed to verify the in vitro ability of beer fermentation residue (BFR) containing Saccharomyces cerevisiae cells and five commercial products that differed in the viability and integrity of S. cerevisiae cells to remove aflatoxin B1 (AFB1) from a citrate-phosphate buffer solution (CPBS). BFR was collected at a microbrewery and prepared by drying and milling. The commercial yeast-based products were as follows: inactive intact yeast cells from beer alcoholic fermentation, inactive intact yeast cells from sugarcane alcoholic fermentation, hydrolyzed yeast cells, yeast cell walls and active yeast cells. Adsorption assays were performed in CPBS spiked with 1.0 μg AFB1/mL at pH 3.0 and 6.0 for a contact time of 60 min at room temperature. Analysis of AFB1 in the samples was performed by high performance liquid chromatography. AFB1 adsorption by the products ranged from 45.5% to 69.4% at pH 3.0 and from 24.0% to 63.8% at pH 6.0. The higher percentages (p < 0.05) of AFB1 binding at both pH values were achieved with products containing hydrolyzed yeast cells or yeast cell walls rather than intact cells. The AFB1 binding percentages of BFR were 55.0 ± 5.0% at pH 3.0 and 49.2 ± 4.5% at pH 6.0, which was not significantly different (p > 0.05) from commercial products containing inactive intact yeast cells. The results of this trial indicate that the yeast-based products tested, especially the BFR, have potential applications in animal feeds as a suitable biological method for reducing the adverse effects of aflatoxins.

Introdução: A presença do vírus da hepatite B (HBV) em indivíduos infectados pelo vírus da imunodeficiência humana (HIV) está associada ao significante aumento da morbimortalidade nos pacientes afetados. Objetivo: Estabelecer a prevalência de marcadores sorológicos de HBV e dos fatores epidemiológicos associados em pacientes HIV+ acompanhados pelo Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR). Métodos: Os dados clinicoepidemiológicos foram coletados por meio de análise retrospectiva dos prontuários e de aplicação de um questionário. Os marcadores anti-HBc total e o antígeno HbsAg foram avaliados pela quimioluminescência por micropartículas. Resultados e discussão: Dos 297 pacientes HIV+, 49,8% apresentaram sorologia positiva somente para anti-HBc e 2,6%, para anti-HBc e HbsAg. A prevalência de marcadores de hepatite B foi significantemente associada à infecção pelo HIV quando comparada com a prevalência observada na população geral da mesma área geográfica (anti-HBc+/HbsAg+: 0,14% vs. 2,6%, odds ratio (OR): 18,82, intervalo de confiança (IC) 95%: 2,34-151,19, p = 0,00052). Em relação aos grupos de risco para infecção pelo HIV, 44,87% dos pacientes com sorologia positiva para HBV informaram terem sido infectados por transmissão sexual. Quanto à faixa etária dos pacientes HIV+/HBV+, 16,66% tinham entre 18-30 anos, 62,82%, entre 31-50 anos e 16,66%, acima dos 50 anos de idade (p = ns). Conclusão: Esses achados corroboram a necessidade de se investigar sistematicamente a presença de marcadores para HBV em pacientes HIV+ das diferentes regiões do país.

Introduction: The presence of hepatitis B virus (HBV) in patients infected by the human immunodeficiency virus (HIV) leads to a higher incidence of liver disorders due to persistence and recurrence of HBV infection in addition to increased morbidity and mortality. Objective: To determine the prevalence of serological markers for hepatitis B in patients infected by HIV followed at Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR). Methods: The clinical and epidemiological data were collected through a questionnaire applied to the patients, as well as a retrospective analysis of medical records. Serum levels of total hepatitis B core antibody (anti-HBc) and surface antigen of the hepatitis B virus (HBsAg) were evaluated through chemiluminescent microparticle immunoassay. Among the 297 HIV+ patients, 49.8% were seropositive only for anti-HBc, and 2.6 % were positive for both markers. Results and discussion: The prevalence of hepatitis B markers was significantly associated with HIV infection when compared with the prevalence observed in the general population from the same geographical area (anti-HBc+ HBsAg+: 0.14% vs. 2.6%, OR: 18.82, 95% CI 2.34-151.19, p = 0.00052). Concerning the associated risks to acquire HIV/HBV infection, 44.87% of the patients reported having been infected through sexual contact. A total of 16.66% HIV/HBV positive patients were in the age group 18-30 years, 62.82% were between 31-50 years and 16.66% were over 60 years old. Conclusion: The findings of the present study corroborate the need to investigate systematically the presence of markers for HBV in HIV+ patients from different regions of the country.

This study aimed to compare Lactobacillus rhamnosus growth in MRS (de Man, Rogosa and Sharpe) broth and a culture medium containing milk whey (MMW) and to evaluate aflatoxin B1 (AFB1) adsorption capacity by bacterial cells produced in both culture media. L. rhamnosus cells were cultivated in MRS broth and MMW (37 °C, 24 hours), and bacterial cell concentration was determined spectrophotometrically at 600 nm. AFB1 (1 µg/ml) adsorption assays were conducted using 1 x 10(10) non-viable L. rhamnosus cells (121 °C, 15 minutes) at pHs 3.0 and 6.0 and contact time of 60 minutes. AFB1 quantification was performed by High Performance Liquid Chromatography. Bacterial cell concentration in MMW was higher (9.84 log CFU/ml) than that in MRS broth (9.63 log CFU/ml). There were no significant differences between AFB1 binding results at the same pH value (3.0 or 6.0) for the cells cultivated in MRS broth (46.0% and 35.8%, respectively) and in MMW (43.7% and 25.8%, respectively), showing that MMW can adequately replace the MRS broth. Therefore, it can be concluded that the use of L. rhamnosus cells cultivated in MMW offers advantages such as reduction in large scale production costs, improvement of environmental sustainability, and being a practicable alternative for decontamination of food products susceptible to aflatoxin contamination.

O objetivo deste estudo foi avaliar o efeito da contagem de células somáticas (CCS) do leite nas frações de caseína do leite longa-vida. Os leites crus foram categorizados em grupos de CCS de baixa (200.000-320.000 células mL-1 ), intermediária (380.000-560.000 células mL-1 ) e alta contagem (600.000-800.000 células mL-1 ). Cinco lotes de leite longa-vida, em cada categoria de CCS, foram analisados por cromatografia líquida de alta eficiência quanto às frações de caseína, após 8, 30, 60, 90 e 120 dias de armazenamento. A CCS apresentou efeito somente sobre a beta-caseína. A alta CCS no leite cru aumenta a proteólise do leite longa-vida, como conseqüência da degradação da beta-caseína.

The objective of this work was to evaluate the effect of somatic cell counts (SCC) in casein fractions of ultra high temperature (UHT) milk. Raw milks were categorized in SCC groups of low (200,000-320,000 cells mL-1), intermediate (380,000-560,000 cells mL-1) and high cells (600,000-800,000 cells mL-1). Five replicates of UHT milks within each SCC category were analyzed for casein fractions after 8, 30, 60, 90 and 120 days of storage through high performance liquid chromatography. SCC showed effect only on beta-casein reduction. SCC in raw milk increases the proteolysis of UHT milk, as a consequence of beta-casein degradation.